Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00453453 · ClinicalTrials.gov registry record · Phase 4
BNP Therapy Observation Unit Outcomes STudy (BOOST)
A Phase 4 study, sponsored by Emory University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 17
- Enrollment target
NCT00453453 is a Phase 4 study that was terminated before completion, run by Emory University. The registered enrollment target is 17 participants.
The verdict
NCT00453453, a Phase 4 study, was terminated before completion, sponsored by Emory University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 17 participants
- Enrollment target
Study Summary
The investigators hypothesize that patients admitted to an emergency department (ED) observation unit will have a decreased rate of hospital admissions and ED recidivism when treated with nesiritide versus standard therapy. The investigators also hypothesize that decreasing B-type Natriuretic Peptide (BNP) levels during treatment in an ED observation unit will predict improved patient outcomes.
Interventions
- DRUG Nesiritide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2007-03 |
| Est. Completion | 2007-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00453453
The ClinicalTrials.gov registry entry for NCT00453453 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Nesiritide is the first listed.
NCT00453453 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00453453 about?
NCT00453453 is a clinical study titled "BNP Therapy Observation Unit Outcomes STudy (BOOST)". The investigators hypothesize that patients admitted to an emergency department (ED) observation unit will have a decreased rate of hospital admissions and ED recidivism when treated with nesiritide versus standard therapy. The investigators also hypothesize that decreasing B-type Natriuretic Peptid...
What is the current status of trial NCT00453453?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 17 participants. The study started on 2007-03. Estimated completion is 2007-09.
What interventions are being tested in trial NCT00453453?
The interventions under investigation include: Nesiritide (DRUG).
Who is sponsoring clinical trial NCT00453453?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.